
Release date: 2026-02-13 17:20:01 Article From: Lucius Laos Recommended: 12
Eltrombopag (generic name: Lucius Pharmaceuticals Eltrombopag Olamine Tablets) prices vary depending on factors such as specifications, place of origin, and purchasing channels. This medication is a prescription drug and must be strictly used under medical supervision; do not adjust the dosage or discontinue use on your own.
Drug Specifications: Prices differ between 25mg and 50mg specifications, with larger doses generally resulting in higher single-treatment costs.
Origin Differences: Imported original brand-name drugs are more expensive due to R&D costs and patent protection, while domestic generic drugs, after passing consistency evaluations, are more competitively priced.
Health Insurance Policies: Some regions include this drug in their health insurance reimbursement catalogs, allowing eligible patients partial coverage; consult local medical institutions for details.
Applicable Population: Primarily used for patients with Immune Thrombocytopenia (ITP) and Aplastic Anemia (AA), and requires evaluation by a hematologist before use.
Monitoring During Treatment: Regular platelet count checks are necessary during treatment to avoid excessive dosing, which may lead to thrombotic risks.
Contraindications and Side Effects: Use with caution in patients with liver dysfunction. Common side effects include headache and nausea; seek medical attention promptly if abnormalities occur.
Offline Channels: Purchase from hospitals or licensed pharmacies to ensure reliable drug sources.
Online Drug Purchase: Some internet hospitals support online consultations followed by prescription issuance; choose legitimate platforms.
Patient Assistance Programs: Certain pharmaceutical companies or charitable organizations offer medication subsidies; patients facing financial difficulties can consult their primary physicians.
This medication requires long-term use. Patients should choose a treatment plan under the guidance of their doctor, considering their individual condition and economic circumstances. Do not trust low-cost drugs from unregulated channels to avoid medication risks.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:1062025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:3822024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:962025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:1202025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:1112025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:1272025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:1222025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:1222025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: